Canasa

Canasa (mesalamine) is an aminosalicylate anti-inflammatory drug prescribed for the treatment of active mild to moderate ulcerative proctitis. It works locally in the rectum to reduce swelling and inflammation.

Dosage by Body Weight

The standard adult dosage is one 1000 mg rectal suppository administered once daily at bedtime. The suppository should be retained for at least one to two hours for optimal effect. Safety and efficacy in pediatric patients have not been established.

  1. Body Weight
    Below 5 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness have not been established in pediatric patients.
  2. Body Weight
    5-7 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness have not been established in pediatric patients.
  3. Body Weight
    8-10 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness have not been established in pediatric patients.
  4. Body Weight
    11-15 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness have not been established in pediatric patients.
  5. Body Weight
    16-20 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness have not been established in pediatric patients.

Formulation

Rectal Suppository

Purpose

Treatment of mildly to moderately active ulcerative proctitis.

Generic Name

Mesalamine

Scheduled Drug

No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.

Alternatives

RowasaPentasaLialdaAprisoAsacol HDDelzicol

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.